Search

Displaying results 7041 - 7050 of 10000 in total
  1. Drug

    Tifurac

    go.drugbank.com/drugs/DB21415
    Experimental

    The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative. Tifurac has a monoisotopic molecular weight of 326.06 Da.

  2. Drug

    Canocapavir

    go.drugbank.com/drugs/DB21570
    Experimental

    The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor. Canocapavir has a monoisotopic molecular weight of 561.08 Da.

  3. Drug

    Emzeltrectinib

    go.drugbank.com/drugs/DB21605
    Experimental

    The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Emzeltrectinib has a monoisotopic molecular weight of 376.13 Da.

  4. Drug

    Zavondemstat

    go.drugbank.com/drugs/DB21608
    Experimental

    The usage of the INN stem '-demstat' in the name indicates that Zavondemstat is a Lysine-specific histone demethylase inhibitor. Zavondemstat has a monoisotopic molecular weight of 431.22 Da.

  5. Drug

    VX-702

    go.drugbank.com/drugs/DB05470
    Investigational

    It acts as a p38 MAP kinase inhibitor. In the future, VX-702 may be investigated for combination with methotrexate, a commonly used therapy for RA.

  6. Drug

    TA-CIN

    go.drugbank.com/drugs/DB05809
    Investigational

    TA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed to generate a strong cellular immune response against HPV-infected cells.

  7. Drug

    NTx-265

    go.drugbank.com/drugs/DB05649
    Investigational

    It is also investigating use of the compound for neurodegenerative disorders, such as Huntington’s disease and Alzheimer’s disease. … In May 2006, biotechnology company Stem Cell Therapeutics started a Phase IIa study of NTx-265.

  8. Drug

    Tefidsogene civaparvovec

    go.drugbank.com/drugs/DB16789
    Investigational

    Tefidsogene civaparvovec, formerly known as SB-913, is an investigational therapy for genome editing. … It consists of an adeno-associated virus (AAV) type 2/6 vector and a zinc finger nuclease (ZFN) system that inserts a correct copy of the Iduronate 2-Sulfatase (IDS) gene into the albumin locus in hepatocytes

  9. Drug

    Methdilazine

    go.drugbank.com/drugs/DB00902
    Approved

    It is used in the treatment of various dermatoses to relieve pruritus.

  10. Drug

    KD7040

    go.drugbank.com/drugs/DB05214
    Investigational

    The KD7040 IND was filed in 4Q06, and a Phase Ib clinical trial began 2Q07. It is being developed by Kalypsys.